The Margin of Moral Duty of Human Being to Participate in Biomedical Research

Author:

Abstract

The existing paradigm of biomedical research ethics, based on respecting the free and informed consent of the research participant, originates from the famous Nuremberg Trial (1947), where the Nazi doctors were convicted of killing and torturing prisoners using medical experiments in German Concentration Camps during World War II. Since the second half of the 20th century, several international instruments have been developed to protect the rights of persons involved in research, considering the voluntariness of participation. Nevertheless, scientific community started to discuss the moral basis of mandatory human participation in biomedical research. Even today, some scholars argue that biomedical research creates public goods in the form of health, safety, and knowledge enjoyed almost by all members of society. The moral duty to participate in research is due to the need for public participation in producing public goods. Others suggest that human beings have a moral obligation to take some risks to help others. So, the moral duty to participate in biomedical research relies on the principles of justice, beneficence, etc. Considering the importance of this issue for research ethics, this article discusses the doctrines and theories, including public goods, free-riding, and beneficence, to set the margin of the moral duty of human beings to participate in biomedical research.

Publisher

European University Institute of Law

Subject

General Medicine

Reference23 articles.

1. 1. The Nuremberg Code, 1996. British Medical Journal, No 7070, Volume: 313. (In English).

2. 2. WMA Declaration of Helsinki - Ethical Principles For Medical Research Involving Human Subjects, available at: (In English).

3. 3. The 1966 International Covenant on Civil and Political Rights, available at: (In English).

4. 4. Guideline for Good Clinical Practice (GCP) E6(R2), International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, EMA/CHMP/ICH, 2017. (In English).

5. 5. Shuster, E., 1997. Fifty Years Later: The Significance of the Nuremberg Code, The New England Journal of Medicine, 337(20). (In English).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3